BOSTON SCIENTIFIC CORPORATION Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) of 25.00% for the 3-month period ending 2012-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Income Statement › Other Income
us-gaap:FairValueInputsLongTermRevenueGrowthRate · last filed 2013-11-05
- BOSTON SCIENTIFIC CORPORATION fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2012-09-30 was 25.00%.
| Period end | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 3 month |
|---|---|
| 2012-09-30 | 25.00% 10-Q · filed 2013-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |